Status:
COMPLETED
Vasopressin Versus Epinephrine in Myomectomy
Lead Sponsor:
CHA University
Conditions:
Uterine Myomas
Eligibility:
FEMALE
18-75 years
Phase:
PHASE3
Brief Summary
Uterine myomas (fibroids or leiomyomas) are the most common benign tumor of the female genital tract and the leading indication for hysterectomy. Although hysterectomy is the definitive treatment of m...
Eligibility Criteria
Inclusion
- women who had myoma-related symptoms such as menorrhagia, pelvic pressure/pain, or infertility
- women who were not pregnant at the time of presentation (i.e., negative for urine pregnancy test or last menstrual period within the last 4 weeks)
- women who were appropriated medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2).
Exclusion
- any pelvic abnormalities requiring concomitant surgery
- the presence of pedunculated subserosal or submucosal myoma as a dominant myoma
- the presence of myoma of maximum diameter 10 cm based on the preoperative ultrasound
- more than 4 myomas
- treatment of GnRH agonist or unipristal acetate within 3 months before surgery
- an inability to understand and provide written informed consent.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01861015
Start Date
May 1 2013
End Date
March 1 2014
Last Update
January 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHA Gangnam Medical Center
Seoul, South Korea, 135-081